tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Technical Analysis

2,146 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Catalyst Pharma is a Buy.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 21.68, while Catalyst Pharma’s (CPRX) share price is $21.27, making it a Sell.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 21.44, while Catalyst Pharma’s (CPRX) share price is $21.27, making it a Sell.

Catalyst Pharma (CPRX) Pivot Points

Dec 22, 2024, 04:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.48
20.79
21.13
21.44
21.77
22.08
22.41
Fibonacci
20.79
21.04
21.19
21.44
21.68
21.84
22.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Dec 22, 2024, 04:11 AM
Period
Simple
Exponential
MA5
21.56Sell
21.47Sell
MA10
21.63Sell
21.59Sell
MA20
21.76Sell
21.68Sell
MA50
21.73Sell
21.44Sell
MA100
20.68Buy
20.50Buy
MA200
18.28Buy
18.61Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 21.59, while Catalyst Pharma’s (CPRX) share price is $21.27, making it a Sell.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 20.50, while Catalyst Pharma’s (CPRX) share price is $21.27, making it a Buy.
Catalyst Pharma’s (CPRX) stock price is $21.27 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 21.73, creating a Sell signal.
Catalyst Pharma’s (CPRX) stock price is $21.27 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 20.68, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $21.27 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 18.28, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Dec 22, 2024, 04:11 AM
Name
Value
Implied Action
RSI (14)
45.60
Neutral
STOCH (9,6)
24.78
Neutral
STOCHRSI (14)
24.78
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
15.11
Buy
Williams %R
-80.40
Buy
CCI (14)
-130.35
Buy
ATR (14)
0.71
-
Ultimate Oscillator
39.61
Neutral
ROC
-5.59
Sell
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 45.60, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 15.11, creating a Buy signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is -130.35, creating a Buy signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is -5.59, creating a Sell signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Hold.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 45.60, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is -0.06, which suggests CPRX is a Buy.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 21.56, which suggests CPRX is a Sell.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 21.76, which suggests CPRX is a Sell.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 21.73, which suggests CPRX is a Sell.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 18.28, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -80.40, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is -130.35, which suggests CPRX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis